Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Inhaled Vaccine
View:
Post by enriquesuave on Dec 22, 2020 10:44am

Inhaled Vaccine

Should try to formulate an inhaled vaccine treatment with TLD-1433. Imo.  Also can combine Rutherin IV with inhaled TLD-1433 formulation prior to X-Ray treatment. IMO
Comment by enriquesuave on Dec 22, 2020 10:48am
For NSCLC   
Comment by Rumpl3StiltSkin on Dec 22, 2020 12:27pm
I think that Doc was also advocating something like this. Too bad we lost Doc ;-(
Comment by NorCalTommy on Dec 22, 2020 9:16pm
Sorry i havent heard... what happened to Doc?
Comment by Rumpl3StiltSkin on Dec 22, 2020 11:58pm
There was a rumor, speculation, that he was bumped for being too reliable a long. He could have come back with a new alias I guess but I don't know. Miss his posts, very informed.
Comment by NorCalTommy on Dec 23, 2020 3:52am
Thanks Rumpl...    I figured as much.... Hempdoc is/was the voice of reason...  and a wealth of knowledg...... He speaks from experience and only one of a few on this board who adds value in that regard........ we are/were VERY lucky to have his insight on this MBoard....  NCT 
Comment by Pandora on Dec 22, 2020 2:08pm
Just released -- not sure if this is a similar vein or what: Guelph, ON December 22nd, 2020 ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSXV:ZEN and OTC:ZENYF) is pleased to announce that it has developed a potential graphene-based antibiotic, antiviral and antifungal compound.  Recently received testing results from the University Health Network/Mount Sinai Hospital ...more  
Comment by CancerSlayer on Dec 22, 2020 2:47pm
Like Silicon, graphene will be facing "big" challenges ahead in not only proving its safety in the human body, but also in convincing the medical community to use it...even if proven safe.  Thankfully, PDT is light years ahead in proven safety & acceptance. BTW, I knew doc was onto something regarding potential delivery mechanisms for TLT's compound... "Delivery ...more  
Comment by tamarindo1 on Dec 22, 2020 4:54pm
Asthma-style inhaler filled with powerful LLAMA antibodies could be used to treat patients with severe COVID-19 Camelids including llamas, camels and alpacas create nanobodies  These are smaller and easier to engineer by experts than human antibodies    Researchers found an nanobody called NIH-CoVnb-112 which binds to viral spike They write  ...more  
Comment by Pandora on Dec 22, 2020 5:18pm
https://www.nih.gov/news-events/news-releases/nih-neuroscientists-isolate-promising-mini-antibodies-against-covid-19-llama
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse